Who are the key players in UK Home Medical Device industry?

Key players in the UK Home Medical Device industry include Philips Healthcare, Medtronic, ResMed, Smith & Nephew, and Abbott. These companies provide a wide range of devices for monitoring, treatment, and long-term care at home, leveraging strong R&D, extensive distribution networks, and innovative product portfolios to maintain market leadership.

What is the UK Home Medical Device growth?

The UK Home Medical Device industry has seen robust growth, especially post-pandemic, with an estimated CAGR of 7% between 2022 and 2024. Philips reported increased demand for its home ventilators and monitoring systems, reflecting the broader trend towards telehealth and at-home patient management solutions.

Which segment accounted for the largest UK Home Medical Device share?

The respiratory care devices segment holds the largest market share within the UK Home Medical Device industry. High prevalence of chronic respiratory conditions like asthma and COPD, combined with increasing use of home nebulizers, CPAP, and oxygen concentrators, has boosted this segment's dominance in recent years.

What are the factors driving the UK Home Medical Device?

Key drivers include rising chronic disease prevalence, aging population, and increased healthcare digitization. For example, ResMed has seen significant adoption of remote patient monitoring devices. NHS initiatives to support home-based care and patient self-management also significantly contribute to market growth.

Which type accounted for the largest UK Home Medical Device share?

By type, diagnostic and monitoring devices such as blood pressure monitors, glucose meters, and pulse oximeters represent the largest market share. Their growing use for daily health management and chronic disease monitoring is driven by user-friendly designs and integration with mobile health platforms.

Home Medical Devices

UK Home Medical Device Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: UK Home Medical Device
Brand: Bussiness Insights

UK Home Medical Device Market: by Type (Monitoring Devices, Therapeutic Devices, Mobility Assist Devices, Diagnostic Devices, Respiratory Devices, Home Telehealth Devices) Application (Diabetes Management, Cardiovascular, Respiratory, Mobility Assistance, Fitness & Wellness, Other Applications), Distribution Channels (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies, Direct Sales, Wholesalers/Distributors, Others), Technology (Digital, Analog, Smart, Connected, Wireless, Wearable), Organization Size (Small, Medium, Large) and By UK Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20126

UK Home Medical Device Market Analysis, 2025-2035

The UK home medical device market is poised for significant expansion between 2025 and 2035, driven by technological innovation, an aging population, and rising chronic disease prevalence. Evolving consumer preferences and the surge in home healthcare needs are shaping demand for monitoring, therapeutic, and mobility-assist devices. Key players are investing in smarter, connected solutions tailored to patient-centric care while navigating regulatory updates, supply chain challenges, and shifting healthcare policies. As digital health adoption accelerates, the market is set to capitalize on new distribution channels and advanced wearable technologies.

Latest Market Dynamics

Key Drivers

Rising demand for remote health monitoring due to an aging population, with Philips Healthcare expanding solutions in 2024.
Increased prevalence of chronic diseases such as diabetes and cardiovascular conditions boosts adoption of home medical technology, as Abbott launched latest glucose monitoring systems in 2024.

Monitoring Devices lead the UK home medical device market, making up 34% of the total share in 2025. The increasing need for real-time health data and proactive care fuels demand for monitoring solutions, especially among aging and chronically ill populations. Therapeutic Devices and Mobility Assist Devices follow at 25% and 15% respectively, underscoring the importance of home-based management of health conditions and improved patient mobility. With the rise in innovative digital health products and a growing emphasis on preventive healthcare, Monitoring Devices are expected to maintain dominance, supported by significant investments from leading industry players.

Diabetes Management dominates the application segment, comprising 30% of the UK home medical device market in 2025. Cardiovascular applications account for 28%, followed by respiratory conditions at 18%. The ongoing rise in lifestyle diseases, combined with public health initiatives for early intervention and self-monitoring, drives patients and caregivers toward these application-driven devices. As innovative solutions for fitness and wellness gain traction, their share is expected to grow, yet the priority remains on chronic disease management for optimal quality of life.

The UK home medical device market is projected to grow from 3,200 million USD in 2020 to 8,700 million USD in 2035. This robust revenue expansion is attributed to increasing adoption of advanced monitoring and therapeutic devices, as well as broader use cases in remote and preventive healthcare. Market acceleration is seen post-2025, reflecting the impact of technological advancements, integration of connected solutions, and positive health policy measures driving device uptake at home.

Year-on-year (YOY) growth in the UK home medical device market demonstrates increased momentum from 2025 onwards, peaking at 8.5% in 2027 before stabilizing to between 6.2% and 4.5% through 2035. The surge is traced to accelerated distribution of smart, connected, and wearable medical technologies alongside growing end-user acceptance and policy support. Fluctuations in YOY growth often reflect the cyclic nature of innovation adoption and regulatory adaptation affecting market performance.

England holds the largest market share for home medical devices in the UK at 68% in 2025, driven by a dense aging population, higher healthcare expenditure, and greater access to advanced digital health infrastructure. Scotland follows with 15%, and Wales accounts for 10%, while Northern Ireland represents 7%. The strong presence in England is expected to persist due to concentration of major healthcare providers and robust funding for digital transformation in care delivery.

Philips Healthcare leads the UK home medical device market with a 17% share in 2025, owing to its wide product portfolio and early adoption of smart technologies. Medtronic and Abbott Laboratories follow with 14% and 12%, respectively, bolstered by extensive R&D investments and strong distribution networks. The remaining market is shared among ResMed, GE Healthcare, and other specialized players, highlighting the competitive yet consolidated nature of the UK home device sector.

Individual consumers represent the largest buyer segment for home medical devices at 42%, reflecting a growing trend toward self-managed health solutions. Healthcare providers, including NHS-backed and private organizations, account for 38%, while pharmacies and wholesalers/distributors contribute 20%. The buyer landscape underscores the decentralized, patient-driven market trajectory dominating the UK's medical device landscape.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	5000
Regions	England, Scotland, Wales, Northern Ireland
Segments	Monitoring Devices, Therapeutic Devices, Mobility Assist Devices, Diagnostic Devices, Respiratory Devices, Home Telehealth Devices; Diabetes Management, Cardiovascular, Respiratory, Mobility Assistance, Fitness & Wellness, Other Applications
Players	Philips Healthcare, Medtronic, ResMed, Abbott Laboratories, Omron Healthcare, GE Healthcare, F. Hoffmann-La Roche, Johnson & Johnson, Smith & Nephew, Becton Dickinson, Boston Scientific, Siemens Healthineers, Stryker, Cardinal Health, Baxter

May 2024: Philips Healthcare unveils new AI-powered home monitoring platform targeting UK's elderly care segment.
June 2024: Abbott launches FreeStyle Libre 4, an advanced CGM system with enhanced connectivity for remote diabetes management in the UK.
July 2024: ResMed debuts its AirView for Home, a cloud-based respiratory device management solution.
August 2024: Johnson & Johnson introduces security updates for its wearable medical devices after reported vulnerabilities.
September 2024: Medtronic announces UK partnership with NHS for pilot of personalized insulin pump technologies.

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

UK Home Medical Device Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

UK Home Medical Device Market Analysis, 2025-2035

Latest Market Dynamics

Key Drivers

Key Opportunities

Key Challenges

Key Restraints

UK Home Medical Device Market Share by Type, 2025

UK Home Medical Device Market Share by Applications, 2025

UK Home Medical Device Market Revenue (USD Million), 2020-2035

UK Home Medical Device Market YOY Growth (%), 2020-2035

UK Home Medical Device Market by Regions Share (%), 2025

UK Home Medical Device Market Players Share (%), 2025

UK Home Medical Device Market Buyers Share (%), 2025

Study Coverage

Key Recent Developments

Frequently asked questions